My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 600

    2.

    Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.

    Ryu JK, Jantaratnotai N, McLarnon JG.

    Neuroscience. 2009 Oct 6;163(2):601-8. Epub 2009 Jul 7.PMID: 19591904 [PubMed - indexed for MEDLINE]Related articles

    3.

    Depletion of neutrophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo.

    Ryu JK, Tran KC, McLarnon JG.

    Glia. 2007 Mar;55(4):439-51.PMID: 17203474 [PubMed - indexed for MEDLINE]Related articles

    4.

    Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.

    Ryu JK, Choi HB, McLarnon JG.

    Neurobiol Dis. 2005 Nov;20(2):550-61.PMID: 15916899 [PubMed - indexed for MEDLINE]Related articles

    5.

    Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.

    Gonçalves M, Estieu-Gionnet K, Berthelot T, Laïn G, Bayle M, Canron X, Betz N, Bikfalvi A, Déléris G.

    Pharm Res. 2005 Aug;22(8):1411-21. Epub 2005 Aug 3.PMID: 16078152 [PubMed - indexed for MEDLINE]Related articles

    6.

    Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.

    Ananth C, Gopalakrishnakone P, Kaur C.

    Hippocampus. 2003;13(3):375-87.PMID: 12722978 [PubMed - indexed for MEDLINE]Related articles

    8.

    Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.

    Shimamura N, Matchett G, Yatsushige H, Calvert JW, Ohkuma H, Zhang J.

    Stroke. 2006 Jul;37(7):1902-9. Epub 2006 Jun 1.PMID: 16741177 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain.

    Ryu JK, Cho T, Wang YT, McLarnon JG.

    J Neuroinflammation. 2009 Dec 23;6:39.PMID: 20030829 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.

    Jhamandas KH, Boegman RJ, Beninger RJ.

    Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. Review.PMID: 7736338 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.

    Figueredo-Cardenas G, Harris CL, Anderson KD, Reiner A.

    Exp Neurol. 1998 Feb;149(2):356-72.PMID: 9500958 [PubMed - indexed for MEDLINE]Related articles

    13.

    A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

    Ryu JK, McLarnon JG.

    J Cell Mol Med. 2009 Sep;13(9A):2911-25. Epub 2008 Jul 24.PMID: 18657226 [PubMed - in process]Related articles

    14.

    Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.

    Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM.

    Mol Psychiatry. 2004 Apr;9(4):371-85.PMID: 14702090 [PubMed - indexed for MEDLINE]Related articles

    15.

    Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

    Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M.

    J Neurosci. 2002 Mar 1;22(5):1967-75.PMID: 11880527 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease.

    Ryu JK, McLarnon JG.

    Neuroreport. 2008 Nov 19;19(17):1715-9.PMID: 18852683 [PubMed - indexed for MEDLINE]Related articles

    17.

    Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

    Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A.

    J Biol Chem. 2003 Sep 12;278(37):35564-73. Epub 2003 Jul 1.PMID: 12837752 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.

    Emerich DF, Mooney DJ, Storrie H, Babu RS, Kordower JH.

    Neurotox Res. 2010 Jan;17(1):66-74. Epub 2009 Jul 9.PMID: 19588214 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antioxidant treatment protects striatal neurons against excitotoxic insults.

    Nakao N, Grasbon-Frodl EM, Widner H, Brundin P.

    Neuroscience. 1996 Jul;73(1):185-200.PMID: 8783241 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.

    Figueredo-Cardenas G, Anderson KD, Chen Q, Veenman CL, Reiner A.

    Exp Neurol. 1994 Sep;129(1):37-56.PMID: 7925841 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk